Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Roden

Showing results (191-200 of 1,010) with videos related to

Pageof 101
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1987
Frequency-dependent interactions of mexiletine and quinidine on depolarization and repolarization in canine Purkinje fibersD M Roden, D H Iansmith, R L Woosley
Biophysical Journal|March 1, 1990
Global parameter optimization for cardiac potassium channel gating modelsJ R Balser, D M Roden, P B Bennett
Current Opinion in Cardiology|March 3, 2012
Genetic determinants of response to cardiovascular drugsQuinn S Wells, Jessica T Delaney, Dan M Roden
International Journal of Antimicrobial Agents|October 29, 2000
Concepts in design of comparative clinical trials of antifungal therapy in neutropenic patientsT J Walsh, M Roden, E Roilides, et al.
British Journal of Pharmacology|June 16, 2009
Probing the mechanisms underlying modulation of quinidine sensitivity to cardiac I(Ks) block by protein kinase A-mediated I(Ks) phosphorylationTao Yang, Hideaki Kanki, Wei Zhang, et al.
Drug Safety|November 23, 2016
On the Potential of Preemptive Genotyping Towards Preventing Medication-Related Adverse Events: Results from the South Korean National Health Insurance DatabaseJonathan S Schildcrout, Joshua C Denny, Dan M Roden
Journal of Cardiovascular Electrophysiology|March 19, 2004
Suppression of bidirectional ventricular tachycardia and unmasking of prolonged QT interval with verapamil in Andersen's syndromePrince J Kannankeril, Dan M Roden, Frank A Fish
Journal of Internal Medicine|March 21, 2009
Free fatty acid kinetics during long-term treatment with pioglitazone added to sulfonylurea or metformin in Type 2 diabetesM Roden, S Mariz, A R Brazzale, et al.
Cardiovascular Clinics|January 1, 1985
Clinical pharmacology of old and new antiarrhythmic drugsL A Siddoway, D M Roden, R L Woosley
American Heart Journal|June 1, 1986
Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient careD M Roden, R L Woosley, R K Primm
Pageof 101

Showing results (191-200 of 1,010) with videos related to

Sort By:
Pageof 101
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1987
Frequency-dependent interactions of mexiletine and quinidine on depolarization and repolarization in canine Purkinje fibersD M Roden, D H Iansmith, R L Woosley
Biophysical Journal|March 1, 1990
Global parameter optimization for cardiac potassium channel gating modelsJ R Balser, D M Roden, P B Bennett
Current Opinion in Cardiology|March 3, 2012
Genetic determinants of response to cardiovascular drugsQuinn S Wells, Jessica T Delaney, Dan M Roden
International Journal of Antimicrobial Agents|October 29, 2000
Concepts in design of comparative clinical trials of antifungal therapy in neutropenic patientsT J Walsh, M Roden, E Roilides, et al.
British Journal of Pharmacology|June 16, 2009
Probing the mechanisms underlying modulation of quinidine sensitivity to cardiac I(Ks) block by protein kinase A-mediated I(Ks) phosphorylationTao Yang, Hideaki Kanki, Wei Zhang, et al.
Drug Safety|November 23, 2016
On the Potential of Preemptive Genotyping Towards Preventing Medication-Related Adverse Events: Results from the South Korean National Health Insurance DatabaseJonathan S Schildcrout, Joshua C Denny, Dan M Roden
Journal of Cardiovascular Electrophysiology|March 19, 2004
Suppression of bidirectional ventricular tachycardia and unmasking of prolonged QT interval with verapamil in Andersen's syndromePrince J Kannankeril, Dan M Roden, Frank A Fish
Journal of Internal Medicine|March 21, 2009
Free fatty acid kinetics during long-term treatment with pioglitazone added to sulfonylurea or metformin in Type 2 diabetesM Roden, S Mariz, A R Brazzale, et al.
Cardiovascular Clinics|January 1, 1985
Clinical pharmacology of old and new antiarrhythmic drugsL A Siddoway, D M Roden, R L Woosley
American Heart Journal|June 1, 1986
Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient careD M Roden, R L Woosley, R K Primm
Pageof 101